Dong Hee Na

5.6k total citations
130 papers, 3.6k citations indexed

About

Dong Hee Na is a scholar working on Molecular Biology, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dong Hee Na has authored 130 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 22 papers in Pharmaceutical Science and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dong Hee Na's work include Advanced Drug Delivery Systems (17 papers), Protein purification and stability (14 papers) and RNA Interference and Gene Delivery (11 papers). Dong Hee Na is often cited by papers focused on Advanced Drug Delivery Systems (17 papers), Protein purification and stability (14 papers) and RNA Interference and Gene Delivery (11 papers). Dong Hee Na collaborates with scholars based in South Korea, United States and Iran. Dong Hee Na's co-authors include Eun Ji Park, Patrick P. DeLuca, Fakhrossadat Emami, Yu Seok Youn, Eun Ji Park, Kang Choon Lee, Alireza Vatanara, Kang Choon Lee, Wonhwa Lee and Yejin Kim and has published in prestigious journals such as Advanced Materials, Nature Nanotechnology and Biomaterials.

In The Last Decade

Dong Hee Na

125 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Hee Na South Korea 36 1.4k 657 457 360 345 130 3.6k
Shashi Bala Singh India 39 2.0k 1.4× 501 0.8× 528 1.2× 464 1.3× 259 0.8× 228 5.3k
Yunjin Jung South Korea 37 2.4k 1.7× 697 1.1× 618 1.4× 425 1.2× 277 0.8× 144 5.6k
Lina Du China 35 1.4k 1.0× 547 0.8× 588 1.3× 538 1.5× 317 0.9× 148 4.0k
Sumeet Gupta India 32 2.6k 1.9× 483 0.7× 360 0.8× 321 0.9× 120 0.3× 173 4.8k
Antonio Di Stefano Italy 40 2.4k 1.7× 485 0.7× 431 0.9× 335 0.9× 417 1.2× 215 5.7k
Mohsen Minaiyan Iran 34 822 0.6× 659 1.0× 621 1.4× 280 0.8× 248 0.7× 167 3.4k
Frédéric Bonté France 27 960 0.7× 403 0.6× 326 0.7× 196 0.5× 168 0.5× 73 3.5k
Jingyuan Wen New Zealand 37 1.4k 1.0× 1.0k 1.5× 495 1.1× 317 0.9× 210 0.6× 124 4.0k
Mariko Hara Japan 26 1.4k 1.0× 307 0.5× 230 0.5× 403 1.1× 313 0.9× 110 3.7k
Gaurav Jain India 34 919 0.7× 1.2k 1.8× 741 1.6× 472 1.3× 176 0.5× 160 3.5k

Countries citing papers authored by Dong Hee Na

Since Specialization
Citations

This map shows the geographic impact of Dong Hee Na's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Hee Na with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Hee Na more than expected).

Fields of papers citing papers by Dong Hee Na

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Hee Na. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Hee Na. The network helps show where Dong Hee Na may publish in the future.

Co-authorship network of co-authors of Dong Hee Na

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Hee Na. A scholar is included among the top collaborators of Dong Hee Na based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Hee Na. Dong Hee Na is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Eun Ju, Ji Won Park, Haewon Park, et al.. (2025). C30 reversed-phase HPLC analysis and in vitro bioactivity evaluation of decursin and decursinol angelate in Angelicae Gigantis Radix. Heliyon. 11(6). e43093–e43093.
2.
Kim, Dohyun, et al.. (2023). Entrapment of celecoxib into mesoporous silica particles for tablets with improved dissolution through amorphization. Journal of Drug Delivery Science and Technology. 84. 104485–104485. 7 indexed citations
3.
Kim, Minkwan, et al.. (2023). Recent Issues and Regulatory Requirements of Data Integrity in Pharmaceutical Industry. Yakhak Hoeji. 67(4). 215–223.
4.
Lee, Wonhwa, et al.. (2022). Application of isothermal chemical denaturation to early‐stage formulation development of fibrinogen. Bulletin of the Korean Chemical Society. 44(4). 348–352. 1 indexed citations
5.
Kim, Hyelim, Boram Son, June Hong Ahn, et al.. (2022). Cleavage‐Responsive Biofactory T Cells Suppress Infectious Diseases‐Associated Hypercytokinemia. Advanced Science. 9(26). e2201883–e2201883. 3 indexed citations
6.
Kim, Hyelim, June Hong Ahn, Kyung Soo Hong, et al.. (2021). Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm. Nano Today. 38. 101149–101149. 27 indexed citations
7.
Park, Hee Ho, Hyelim Kim, Ji-Eun Kim, et al.. (2021). PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials. 273. 120827–120827. 41 indexed citations
8.
Li, Cheng-Ru, et al.. (2020). A Review of MADS-box Genes,the Molecular Regulatory Genes for Floral Organ Development in Orchidaceae. Acta Horticulturae Sinica. 47(10). 2047. 8 indexed citations
9.
Park, Eun Ji, Ji-Young Choi, Kang Choon Lee, & Dong Hee Na. (2019). Emerging PEGylated non-biologic drugs. Expert Opinion on Emerging Drugs. 24(2). 107–119. 52 indexed citations
10.
Oh, Yumin, Magdalena Swierczewska, Tae Hyung Kim, et al.. (2015). Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors. Journal of Controlled Release. 220(Pt B). 671–681. 21 indexed citations
11.
Son, Sohee, Sung Mook Lim, Su Young Chae, et al.. (2015). Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects. International Journal of Pharmaceutics. 495(1). 81–86. 12 indexed citations
12.
Ji, Hye Young, et al.. (2011). Liquid chromatography–electrospray ionization tandem mass spectrometry for the quantification of styraxlignolide A in rat plasma. Journal of Separation Science. 34(15). 1828–1833. 2 indexed citations
13.
Na, Dong Hee. (2011). Determination of the Trace Element in Pearl Powder. Anhui nongye kexue. 2 indexed citations
14.
Li, Chengqi, et al.. (2010). Quantitative inheritance for main plant architecture traits of upland cotton variety Baimian 1.. Mianhua xuebao. 22(5). 415–421. 6 indexed citations
15.
Na, Dong Hee. (2010). Failure Analysis of Rear Beam of Horizontal Stabilizer in Airplane. 1 indexed citations
16.
Hu, Tiezhu, et al.. (2009). Analysis of grain filling characteristics of different wheat varieties.. Mailei zuowu xuebao. 29(4). 643–646. 2 indexed citations
17.
Park, Eun Ji, Kang Choon Lee, & Dong Hee Na. (2009). Separation of positional isomers of mono-poly(ethylene glycol)-modified octreotides by reversed-phase high-performance liquid chromatography. Journal of Chromatography A. 1216(45). 7793–7797. 13 indexed citations
18.
Na, Dong Hee, et al.. (2006). Effect of Molecular Size of PEGylated Recombinant Human Epidermal Growth Factor on the Biological Activity and Stability in Rat Wound Tissue. Pharmaceutical Development and Technology. 11(4). 513–519. 23 indexed citations
19.
Na, Dong Hee, Yu Seok Youn, Eun Ji Park, et al.. (2003). Stability of PEGylated salmon calcitonin in nasal mucosa. Journal of Pharmaceutical Sciences. 93(2). 256–261. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026